Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bustoros

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2021
Regular Aspirin Use and Mortality in Patients with Multiple MyelomaCatherine R Marinac, Dong Hoon Lee, Graham A Colditz, et al.
American Journal of Hematology|February 14, 2023
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemiaMateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz, et al.
Haematologica|January 29, 2026
Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myelomaJiani N Chai, Paul Dennis Simonson, Kameisha Gulgar, et al.
Surgical Neurology International|September 15, 2016
Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reportsVineet Tyagi, Jason Theobald, James Barger, et al.
Neoplasia (New York, N.Y.)|December 17, 2016
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.
Cancers|November 27, 2021
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical FeaturesAhmed Ebada Salem, Yehia H Zaki, Gamal El-Hussieny, et al.
Blood|October 28, 2018
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patientsRomanos Sklavenitis-Pistofidis, Marzia Capelletti, Chia-Jen Liu, et al.
Plos One|October 5, 2018
Profiling of circulating exosomal miRNAs in patients with Waldenström MacroglobulinemiaJuliette M Bouyssou, Chia-Jen Liu, Mark Bustoros, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and DexamethasoneOmar Nadeem, Michelle P Aranha, Robert Redd, et al.
Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2021
Regular Aspirin Use and Mortality in Patients with Multiple MyelomaCatherine R Marinac, Dong Hoon Lee, Graham A Colditz, et al.
American Journal of Hematology|February 14, 2023
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemiaMateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz, et al.
Haematologica|January 29, 2026
Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myelomaJiani N Chai, Paul Dennis Simonson, Kameisha Gulgar, et al.
Surgical Neurology International|September 15, 2016
Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reportsVineet Tyagi, Jason Theobald, James Barger, et al.
Neoplasia (New York, N.Y.)|December 17, 2016
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.
Cancers|November 27, 2021
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical FeaturesAhmed Ebada Salem, Yehia H Zaki, Gamal El-Hussieny, et al.
Blood|October 28, 2018
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patientsRomanos Sklavenitis-Pistofidis, Marzia Capelletti, Chia-Jen Liu, et al.
Plos One|October 5, 2018
Profiling of circulating exosomal miRNAs in patients with Waldenström MacroglobulinemiaJuliette M Bouyssou, Chia-Jen Liu, Mark Bustoros, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and DexamethasoneOmar Nadeem, Michelle P Aranha, Robert Redd, et al.
Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Pageof 4